GE Healthcare(GEHC)
GE HealthCare is a subsidiary of American multinational conglomerate General Electric incorporated in New York and headquartered in Chicago, Illinois. As of 2017, it is a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures. It offers dyes used in magnetic-resonance-imaging procedures; manufactures medical diagnostic equipment, including CT image machines; MRI, XRAY; Ultrasound; Cath Labs; Mamogram; Nuclear Medicine Cameres; and develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. It was incorporated in 1994 and operates in more than 100 countries.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Adreview | Iobenguane i | 2008-09-19 | — | |
| Amipaque | Metrizamide | 1982-01-01 | — | |
| Bilopaque | Tyropanoate | 1982-01-01 | — | |
| Clariscan | Gadoterate meglumine | 2019-11-01 | — | |
| Datscan | Ioflupane (123l), Ioflupane i | 2000-07-27 | — | |
| Dicopac | Cyanocobalamin, Cyanocobalamin co | 1982-01-01 | ||
| Gallium ga | Gallium ga | 1982-01-01 | ||
| Hypaque | Diatrizoate, Diatrizoate meglumine | 1982-01-01 | — |
1
2
3
4
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use